Purchase any WEBINAR and get
10% Off
CODE: SAVE10
T&C applicable, please referFAQ
Validity : 21st Apr'24 to 01st May'24
Gmo Food Labeling In The U.S.A. What To Expect From The Final Rule
- Basic requirements of the National Bioengineered Food Disclosure Proposed Rule
- Ingredients Subject to Disclosure
- Acceptable labelling methods for Disclosure
- GMO Disclosure symbols that May be Used
- Thresholds of Bioengineered foods and exemptions
- Timelines for Implementation of the Proposed Rule
Overview of the webinar
The USDA recently unveiled its long-awaited proposed GMO Labeling Disclosure regulation, the National Bioengineered Food Disclosure Standard, which provides food companies with guidance about how to label products made with genetically modified ingredients. This important proposed rule implements the National Bioengineered Food Disclosure Law of 2016 and will impact most food companies and their products. The webinar will help you learn how to comply with all the essential requirements of this rule and how it affects your product labels.
Who should attend?
- Regulatory Affairs managers and associates
- Food labelling managers and associates
- Food marketing managers
- Product managers in the food industry
Why should you attend?
The recently issued National Bioengineered Food Disclosure Standard provides food companies with learn how guidance about how to label products made with genetically modified ingredients. This significant proposed rule implements the National Bioengineered Food Disclosure Law of 2016 and will impact most food companies and their products. The webinar will help you learn all the essential requirements of this rule and how it affects your products.
Faculty - Ms.Norma Skolnik
Norma Skolnik has over 35 years of regulatory experience working with the pharmaceutical and dietary supplement industries. She served as Director of Regulatory Affairs for the Americas for Cadbury Adams. Prior to that she was Director of Regulatory Affairs for the Adams Division of Pfizer and Associate Director Of Regulatory Affairs for the Warner-Lambert company. She also served as Director of Regulatory Affairs for Lederle Consumer Healthcare and as Associate Director of Marketed Product Support for Lederle Laboratories and Associate Director of Regulatory Affairs for Wyeth.